A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics, Pharmacodynamics Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics, Pharmacodynamics Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 03 Mar 2015

At a glance

  • Drugs DP 4088 (Primary)
  • Indications Blood coagulation disorders; Embolism and thrombosis
  • Focus Pharmacokinetics
  • Sponsors Diakron Pharmaceuticals
  • Most Recent Events

    • 23 Feb 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 27 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top